Lead Product(s) : Benzgalantamine gluconate
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Alpha Cognition Shows Positive Data for ALPHA-1062 in Brain Injury Model
Details : ALPHA-1062 (benzgalantamine gluconate) is a cholinesterase inhibitor being investigated for the treatment of mild traumatic brain injury.
Product Name : ALPHA-1062
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 01, 2025
Lead Product(s) : Benzgalantamine gluconate
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
